Virginia López-Alonso1, Binith Cheeran2, Dan Río-Rodríguez1, Miguel Fernández-Del-Olmo3. 1. Faculty of Sciences of Sport and Physical Education, Department of Physical Education, University of A Coruña, Av. Ernesto Che Guevara 121, Pazos-Liáns, 15179 Oleiros, A Coruña, Spain. 2. Department of Neurology, John Radcliffe Hospital, Headington, Oxford, UK; Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK. 3. Faculty of Sciences of Sport and Physical Education, Department of Physical Education, University of A Coruña, Av. Ernesto Che Guevara 121, Pazos-Liáns, 15179 Oleiros, A Coruña, Spain. Electronic address: mafo@udc.es.
Abstract
BACKGROUND: Non-invasive Brain Stimulation (NIBS) paradigms are unique in their ability to safely modulate cortical plasticity for experimental or therapeutic applications. However, increasingly, there is concern regarding inter-individual variability in the efficacy and reliability of these paradigms. HYPOTHESIS: Inter-individual variability in response to NIBS paradigms would be better explained if a multimodal distribution was assumed. METHODS: In three different sessions for each subject (n = 56), we studied the Paired Associative Stimulation (PAS25), Anodal transcranial DC stimulation (AtDCS) and intermittent theta burst stimulation (iTBS) protocols. We applied cluster analysis to detect distinct patterns of response between individuals. Furthermore, we tested whether baseline TMS measures (such as short intracortical inhibition (SICI), resting motor threshold (RMT)) or factors such as time of day could predict each individual's response pattern. RESULTS: All three paradigms show similar efficacy over the first hour post stimulation--there is no significant effect on excitatory or inhibitory circuits for the whole sample, and AtDCS fares no better than iTBS or PAS25. Cluster analysis reveals a bimodal response pattern--but only 39%, 45% and 43% of subjects responded as expected to PAS25, AtDCS, and iTBS respectively. Pre-stimulation SICI accounted for 10% of the variability in response to PAS25, but no other baseline measures were predictive of response. Finally, we report implications for sample size calculation and the remarkable effect of sample enrichment. CONCLUSION: The implications of the high rate of 'dose-failure' for experimental and therapeutic applications of NIBS lead us to conclude that addressing inter-individual variability is a key area of concern for the field.
BACKGROUND: Non-invasive Brain Stimulation (NIBS) paradigms are unique in their ability to safely modulate cortical plasticity for experimental or therapeutic applications. However, increasingly, there is concern regarding inter-individual variability in the efficacy and reliability of these paradigms. HYPOTHESIS: Inter-individual variability in response to NIBS paradigms would be better explained if a multimodal distribution was assumed. METHODS: In three different sessions for each subject (n = 56), we studied the Paired Associative Stimulation (PAS25), Anodal transcranial DC stimulation (AtDCS) and intermittent theta burst stimulation (iTBS) protocols. We applied cluster analysis to detect distinct patterns of response between individuals. Furthermore, we tested whether baseline TMS measures (such as short intracortical inhibition (SICI), resting motor threshold (RMT)) or factors such as time of day could predict each individual's response pattern. RESULTS: All three paradigms show similar efficacy over the first hour post stimulation--there is no significant effect on excitatory or inhibitory circuits for the whole sample, and AtDCS fares no better than iTBS or PAS25. Cluster analysis reveals a bimodal response pattern--but only 39%, 45% and 43% of subjects responded as expected to PAS25, AtDCS, and iTBS respectively. Pre-stimulation SICI accounted for 10% of the variability in response to PAS25, but no other baseline measures were predictive of response. Finally, we report implications for sample size calculation and the remarkable effect of sample enrichment. CONCLUSION: The implications of the high rate of 'dose-failure' for experimental and therapeutic applications of NIBS lead us to conclude that addressing inter-individual variability is a key area of concern for the field.
Authors: L Labruna; A Stark-Inbar; A Breska; M Dabit; B Vanderschelden; M A Nitsche; R B Ivry Journal: Brain Stimul Date: 2019-03-13 Impact factor: 8.955
Authors: A J Woods; A Antal; M Bikson; P S Boggio; A R Brunoni; P Celnik; L G Cohen; F Fregni; C S Herrmann; E S Kappenman; H Knotkova; D Liebetanz; C Miniussi; P C Miranda; W Paulus; A Priori; D Reato; C Stagg; N Wenderoth; M A Nitsche Journal: Clin Neurophysiol Date: 2015-11-22 Impact factor: 3.708